台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    29.00
  • 漲跌
    ▲0.05
  • 漲幅
    +0.17%
  • 成交量
    1,338
  • 產業
    上市 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
神隆 (1789)籌碼相關-富邦-縣政 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-縣政 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2023/07/2100.00232.2531.50-22,801-0.07%
2023/07/201431.331731.0131.30-32,686-0.11%
2023/07/191033.9500.0033.35102,3900.42%
2023/07/181034.81335.3333.7072,2130.32%
2023/07/17233.15333.2533.25-11,891-0.05%
2023/07/1400.006629.6030.25-661,806-3.65%
2023/07/12128.850.128.9028.950.91,8200.05%
2023/07/11429.4900.0029.4541,8590.22%
2023/07/10629.23329.0529.5031,8490.16%
2023/07/051029.5800.0029.40101,7530.57%
2023/07/0400.0018229.9429.75-1821,727-10.53% 大賣/鉅額交易
2023/07/0300.00130.0029.75-11,703-0.06%
2023/06/30330.35730.1530.25-41,655-0.24%
2023/06/2900.00229.5529.50-21,584-0.13%
2023/06/2800.00429.1029.40-41,538-0.26%
2023/06/27128.80229.0528.75-11,495-0.07%
2023/06/265.128.8300.0028.755.11,4810.35%
2023/06/2100.001629.0028.95-161,476-1.08%
2023/06/20428.7800.0028.9041,4470.28%
2023/06/1900.00229.2029.00-21,410-0.14%
2023/06/16128.30229.0528.60-11,356-0.07%
2023/06/1500.00228.0028.05-21,274-0.16%
2023/06/1300.00427.6027.70-41,214-0.33%
2023/06/1200.00227.1526.90-21,177-0.17%
2023/06/0700.00226.8526.90-21,164-0.17%
2023/06/0600.00226.5526.50-21,169-0.17%
2023/05/193726.3800.0026.35371,2143.05%
2023/05/15225.9000.0025.9021,1580.17%
2023/05/085027.9300.0027.55501,1674.28%
2023/05/05428.1500.0028.1541,1640.34%
2023/05/04328.1000.0028.5531,1750.26%
2023/05/031028.3500.0028.30101,1680.86%
2023/05/0200.00228.8028.65-21,171-0.17%
2023/04/28028.30028.9528.4001,1540.00%
2023/04/2710528.38228.0128.301031,0799.53% 大買/鉅額交易
2023/04/2500.00227.5027.15-21,011-0.20%
2023/04/21526.80526.7026.6501,0030.00%
2023/04/18327.7000.0027.2539900.30%
2023/04/1700.00228.1527.75-2971-0.21%
2023/04/1400.00626.6827.00-6931-0.64%
2023/04/1300.002026.4126.35-20884-2.26%
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章